MD Anderson Cancer Center in Houston has initiated orders of Cesium-131 brachytherapy seeds from IsoRay, as it continues its clinical research study investigating brachytherapy's ability to help control intermediate risk prostate cancer, which is a classification of early stage prostate cancer that has shown a tendency to recur following standard treatment.

California Gov. Edmund G. Brown Jr. has vetoed SB 791, which would have required mammography providers to notify women about their breast density and potential benefits of additional screening.

Medicare payments for acute ischemic stroke patients who underwent endovascular embolectomy did not adequately reimburse hospital costs, according to a report published online in the Oct. 6 issue of Stroke. Even when patients had a good outcome, reimbursement fell $15,000 short of costs, the analysis found.

The shift in the driver of baseline spending growth away from increases in spending per beneficiary toward demographic changes has important policy implications for Medicare, according to a perspective paper published Oct. 6 in The New England Journal of Medicine.

Patients with stable coronary artery disease (CAD) who had high coronary collateral circulation showed a significantly reduced mortality risk compared with patients with low collateralization, according to the results of a meta-analysis published online Oct. 3 in the European Heart Journal.

An Institute of Medicine (IOM) committee has made six recommendations to the Department of Health and Human Services (HHS), for the process of defining essential health benefits (EHBs), mandated under the Patient Protection and Affordable Care Act (PPACA). The HHS sought recommendations from the IOM in defining EHBs offered by health plans participating in newly created state health insurance exchanges.

North Mississippi Medical Center has installed Toshiba America Medical Systems' Infinix DP-i, a single-room x-ray for cardiac and general angiography.

Researchers at Lawrence Livermore National Laboratory in Livermore, Calif., recently received $3 million from the National Institutes of Health to acquire a new biomedical accelerator mass spectrometry instrument. The instrument will provide analysis for medical and other biological research.